title: [Effects of octreotide on fatty infiltration of the pancreas in high-fat diet induced obesity rats].
abstract: OBJECTIVE
  To investigate effects of octreotide on fatty infiltration of the pancreas in high-fat diet induced obesity rats.
  
  
  METHODS
  SD rats were divided into control group (n = 14) and high-fat diet group (n = 36). Obese rats from the high-fat diet group were further divided into 2 groups: the obese group (n = 14) and the octreotide-treated group (n = 16). Rats in the octreotide-treated group were subcutaneously injected with octreotide per 12 h (40 mg/kg BW) for 8 days. Body weight, fasting plasma glucose (FPG), fasting serum insulin, triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) levels, pancreatic TG and FFA content were measured. Homeostatic model assessment (HOMA) index was calculated. Somatostatin (SST) and the expression of adipose differentiation-related protein (ADFP) in pancrea were measured. Pathological changes of pancreas were examined with light microscopy.
  
  
  RESULTS
  Body weight, Lee's index, FPG, fasting serum insulin, TG, TC levels and HOMA index in the obese group were higher than those in the control group (P < 0.05), while the level of HDL-C in the obese group was lower than that in the control group (P < 0.05). Pancreatic TG, FFA contents and expression of ADFP in the obese group were significantly higher than those in the control group (P < 0.05), while pancreatic SST level in the obese group was lower than that in the control group (P < 0.05). Obvious pancreatic intra-lobular fatty infiltration was observed in the obese group. After treatment of octreotide, body weight, HOMA index, as well as other plasma parameters as above showed decrease as compared with those in the obese group (P < 0.05). In addition, pancreatic TG, FFA contents and the expression of ADFP in the octreotide treated group were also significantly decreased compared with those in the obese group (P < 0.05), pancreatic SST level was increased in the octreotide treated group than that in the obese group (P < 0.05), and pancreatic intra-lobular fatty infiltration was alleviated.
  
  
  CONCLUSIONS
  Octreotide might improve pancreatic fatty infiltration, lipid disorder, insulin resistance and alleviate pancreatic injury by down-regulating the expression of ADFP in pancreas, and lowering the levels of plasma glucose and lipid in the high-fat diet induced obesity rats.
authors.forename: Tao
authors.initials: T
authors.lastname: Yu
authors.forename: Rui
authors.initials: R
authors.lastname: Liu
authors.forename: Mao
authors.initials: M
authors.lastname: Li
authors.forename: Xian
authors.initials: X
authors.lastname: Li
authors.forename: Ou
authors.initials: O
authors.lastname: Qiang
authors.forename: Wei
authors.initials: W
authors.lastname: Huang
authors.forename: Chengwei
authors.initials: C
authors.lastname: Tang
mesh_terms: D000818:Animals; D001835:Body Weight; D002784:Cholesterol; D008076:Cholesterol, HDL; D059305:Diet, High-Fat; D005215:Fasting; D007333:Insulin Resistance; D008055:Lipids; D008565:Membrane Proteins; D023421:Models, Animal; D009765:Obesity; D015282:Octreotide; D010179:Pancreas; D000070780:Perilipin-2; D051381:Rats; D017207:Rats, Sprague-Dawley; D014280:Triglycerides
chemical_list: D008076:Cholesterol, HDL; D008055:Lipids; D008565:Membrane Proteins; D000070780:Perilipin-2; C000602984:Plin2 protein, rat; D014280:Triglycerides; D002784:Cholesterol; D015282:Octreotide